Skip to main content
SpringerLink
Log in

Oxidized lipoprotein(a) and cardio-ankle vascular index (CAVI) in hypertensive subjects

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

While oxidized lipoprotein(a) (oxLp(a)) has been indicated to be involved in atherogenesis more than native lipoprotein(a) (Lp(a)), there is still a need to elucidate the associations among oxLp(a), hypertension, and atherosclerosis. The cardio-ankle vascular index (CAVI) is a recently developed index used to assess arterial stiffness that is independent of blood pressure components. The present study investigated the correlation between oxLp(a) and the CAVI among hypertensive subjects. Clinical data, including general atherosclerotic risk factors, in addition to Lp(a), oxLp(a), and the CAVI, were collected from 72 non-smoking, asymptomatic, and untreated female subjects (mean age: 64.3 years). Correlations between the CAVI and Lp(a) or oxLp(a) were examined in a hypertensive group (n = 34) and a non-hypertensive control group (n = 38). There was a significant and positive correlation between the CAVI and subject age in the control group, while there was a significant and positive correlation between the CAVI and subject age, systolic blood pressure, and oxLp(a) (r = 0.38, p < 0.05) in the hypertensive group. A stepwise multiple linear regression analysis identified the oxLp(a) to be correlated independently, significantly, and positively with the CAVI (β = 0.30, p < 0.05) in the hypertensive group, while this correlation was not significant in the control group. These findings suggest that the oxidative modification of Lp(a) may be associated with arterial stiffness in hypertensive, but not non-hypertensive, female subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scanu AM (2003) Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications. Curr Atheroscler Rep 5:106–113

    Article  PubMed  Google Scholar 

  2. Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412–423

    Google Scholar 

  3. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A; European Atherosclerosis Society Consensus Panel (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31:2844–2853

    Google Scholar 

  4. Holvet P (2004) Oxidized LDL and coronary heart disease. Acta Cardiol 59:279–484

    Google Scholar 

  5. Zioncheck TF, Powell LM, Rice GC, Eaton DL, Lawn RM (1991) Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest 87:767–771

    Article  PubMed  CAS  Google Scholar 

  6. Haberland ME, Fless GM, Scanu AM, Fogelman AM (1992) Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte–macrophages. J Biol Chem 267:4143–4151

    PubMed  CAS  Google Scholar 

  7. Riis-Hansen P, Kharazmi A, Jauhiainen M, Ehnholm C (1994) Induction of oxygen free radical generation in human monocytes by lipoprotein(a). Eur J Clin Invest 24:497–499

    Article  PubMed  CAS  Google Scholar 

  8. Galle J, Bengen J, Schollmeyer P, Wanner C (1995) Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Circulation 92:1582 –1589

    Article  PubMed  Google Scholar 

  9. Beaudeux JL, Césarini ML, Gardès-Albert M, Maclouf J, Merval R, Esposito B, Peynet J, Tedqui A (1997) Native and gamma radiolysis-oxidized lipoprotein(a) increase the adhesiveness of rabbit aortic endothelium. Atherosclerosis 132:29–35

    Article  PubMed  CAS  Google Scholar 

  10. Ren S, Man RY, Angel A, Shen GX (1997) Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells. Atherosclerosis 128:1–10

    Article  PubMed  CAS  Google Scholar 

  11. Morishita R, Yamada S, Higaki J, Tomita N, Kida I, Aoki M, Moriguchi A, Hayashi S, Sakurabayashi I, Kaneda Y, Ogihara T (1998) Conditioned medium from HepG2 cells transfected with human apolipoprotein(a) gene stimulates growth of human vascular smooth muscle cells: effects of overexpression of human apolipoprotein(a) gene. Hypertension 32:215–222

    Article  PubMed  CAS  Google Scholar 

  12. Yamada S, Morishita R, Nakamura S, Ogihara T, Kusumi Y, Sakurai I, Kubo N, Sakurabayashi I (2000) Development of antibody against epitope of lipoprotein(a) modified by oxidation: evaluation of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a). Circulation 102:1639–1644

    Article  PubMed  CAS  Google Scholar 

  13. Komai N, Morishita R, Yamada S, Oishi M, Iguchi S, Aoki M, Sasaki M, Sakurabayashi I, Higaki J, Ogihara T (2002) Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells. Hypertension 40:310–314

    Article  PubMed  CAS  Google Scholar 

  14. Morishita R, Ishii J, Kusumi Y, Yamada S, Komai N, Ohishi M, Nomura M, Hishida H, Niihashi M, Mitsumata M (2009) Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vascular wall. J Atheroscler Thromb 16:410–418

    Article  PubMed  CAS  Google Scholar 

  15. Umahara T, Uchihara T, Yamada S, Hashimoto T, Akimoto J, Haraoka J, Iwamoto T (2011) Differential expression of oxidized/native lipoprotein(a) and plasminogen in human carotid and cerebral artery plaques. Atherosclerosis 215:392–398

    Article  PubMed  CAS  Google Scholar 

  16. Kotani K, Yamada S, Uurtuya S, Yamada T, Taniguchi N, Sakurabayashi I (2010) The association between blood glucose and oxidized lipoprotein(a) in healthy young women. Lipids Health Dis 9:103

    Article  PubMed  Google Scholar 

  17. Kotani K, Yamada S, Yamada T, Taniguchi N, Sakurabayashi I (2011) The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: a comparison with native lipoprotein(a). Lipids Health Dis 10:174

    Article  PubMed  CAS  Google Scholar 

  18. Rodrigo R, González J, Paoletto F (2011) The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res 34:431–440

    Article  PubMed  CAS  Google Scholar 

  19. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI (1995) Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 26:485–490

    Article  PubMed  CAS  Google Scholar 

  20. Lehmann ED (1999) Clinical value of aortic pulse-wave velocity measurement. Lancet 354:528–529

    Article  PubMed  CAS  Google Scholar 

  21. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113:657–663

    Article  PubMed  Google Scholar 

  22. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113:664–670

    Article  PubMed  Google Scholar 

  23. Yamashina A, Tomiyama H, Arai T, Koji Y, Yambe M, Motobe H, Glunizia Z, Yamamoto Y, Hori S (2003) Nomogram of the relation of brachial-ankle pulse wave velocity with blood pressure. Hypertens Res 26:801–806

    Article  PubMed  Google Scholar 

  24. Shirai K, Utino J, Otsuka K, Takata M (2006) A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 13:101–107

    Article  PubMed  Google Scholar 

  25. Kotani K, Miyamoto M, Taniguchi N (2010) Clinical significance of the cardio-ankle vascular index (CAVI) in hypertension. Curr Hypertens Rev 6:251–253

    Article  Google Scholar 

  26. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M (2011) Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 18:924–938

    Article  PubMed  Google Scholar 

  27. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252

    Google Scholar 

  28. Yamada S, Inoue K, Morishita R, Ogihara T, Kubono K, Kubo N, Abe A, Sakurabayashi I (1999) A new Lp(a) assay that is unaffected by apo(a) size polymorphism. Clin Chim Acta 287:29–43

    Article  PubMed  CAS  Google Scholar 

  29. Homma Y (2004) Predictors of atherosclerosis. J Atheroscler Thromb 11:265–270

    Article  PubMed  CAS  Google Scholar 

  30. Evans M (2011) Total lipid management and residual risk: beyond statin therapy. Br J Hosp Med (Lond) 72:132–136

    Google Scholar 

  31. Taguchi M, Ishigami M, Nishida M, Moriyama T, Yamashita S, Yamamura T (2011) Remnant lipoprotein-cholesterol is a predictive biomarker for large artery atherosclerosis in apparently healthy women: usefulness as a parameter for annual health examinations. Ann Clin Biochem 48:332–337

    Article  PubMed  CAS  Google Scholar 

  32. Taleb A, Witztum JL, Tsimikas S (2012) Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events. Biomark Med 5:673–694

    Article  Google Scholar 

  33. Bhavani AB, Padma T, Sastry KB, Reddy NK (2003) Plasma lipoprotein(a) levels in patients with untreated essential hypertension. Indian J Hum Genet 9:65–68

    Google Scholar 

  34. Serban C, Nicola T, Mateescu R, Noveanu L, Susan L, Pacurari A, Caraba A, Romoşan I, Cristescu A (2010) Serum lipoprotein (a) levels in patients with arterial hypertension. Rev Med Chir Soc Med Nat Iasi 114:798–802

    PubMed  Google Scholar 

  35. Nagayama D, Saiki A, Endo K, Yamaguchi T, Ban N, Kawana H, Ohira M, Oyama T, Miyashita Y, Shirai K (2010) Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients. Int J Clin Pract 64:1796–1801

    Article  PubMed  CAS  Google Scholar 

  36. Miyashita Y, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K (2009) Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb 16:621–626

    Article  PubMed  CAS  Google Scholar 

  37. Miyashita Y, Endo K, Saiki A, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K (2009) Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb 16:539–545

    Article  PubMed  CAS  Google Scholar 

  38. Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K (2009) Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb 16:568–575

    Article  PubMed  CAS  Google Scholar 

  39. Ishimitsu T, Numabe A, Masuda T, Akabane T, Okamura A, Minami J, Matsuoka H (2009) Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension. Hypertens Res 32:962–968

    Article  PubMed  CAS  Google Scholar 

  40. Madamanchi NR, Hakim ZS, Runge MS (2005) Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Thromb Haemos 3:254–267

    Article  CAS  Google Scholar 

  41. Tavridou A, Efthimiadis A, Efthimiadis I, Manolopoulos VG (2010) Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia. Heart Vessels 25:288–293

    Article  PubMed  Google Scholar 

  42. Miyoshi T, Doi M, Hirohata S, Kamikawa S, Usui S, Ogawa H, Sakane K, Izumi R, Ninomiya Y, Kusachi S (2011) Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients. Heart Vessels 26:408–413

    Article  PubMed  Google Scholar 

  43. Chien KL, Lee YT, Sung FC, Su TC, Hsu HC, Lin RS (1999) Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors. Atherosclerosis 143:267–273

    Article  PubMed  CAS  Google Scholar 

  44. No authors listed (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of Systolic Hypertension in the Elderly (SHEP). SHEP cooperative research group. JAMA 265:3255–3264

    Google Scholar 

Download references

Acknowledgments

This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (K.K) and the Foundation for the Development of the Community, Japan.

Conflict of interest

The authors have no conflicts of interest to report. The authors alone are responsible for the content and writing of this article.

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Kazuhiko Kotani, Toshiyuki Yamada & Nobuyuki Taniguchi

  2. Central Research Institute, Shino-Test Corporation, Kanagawa, Japan

    Shingo Yamada

  3. Department of Cardiology, Jichi Medical University, Tochigi, Japan

    Kazuomi Kario

Authors
  1. Kazuhiko Kotani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shingo Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiyuki Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuomi Kario
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nobuyuki Taniguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuhiko Kotani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kotani, K., Yamada, S., Yamada, T. et al. Oxidized lipoprotein(a) and cardio-ankle vascular index (CAVI) in hypertensive subjects. Heart Vessels 28, 461–466 (2013). https://doi.org/10.1007/s00380-012-0265-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-012-0265-2

Keywords

Search

Navigation